Phase IIa trial of lipsomal ciprofloxacin for the prevention of respiratory tract infections in cystic fibrosis patients.

Trial Profile

Phase IIa trial of lipsomal ciprofloxacin for the prevention of respiratory tract infections in cystic fibrosis patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Oct 2008

At a glance

  • Drugs Ciprofloxacin (Primary)
  • Indications Cystic fibrosis-associated respiratory tract infections; Pseudomonal infections
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Oct 2008 Results reported at the 22nd Annual North American Cystic Fibrosis conference, according to an Aradigm media release.
    • 30 Jul 2008 Interim results reported in an Aradigm Corporation media release.
    • 14 May 2008 Aradigm Corporation expects to report results in the first quarter of 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top